Solventum director exercises 3,403 RSUs

Solventum Corp director John H. Weiland exercised 3,403 Restricted Stock Units into 3,403 shares of Common Stock on April 30, 2026.

Rhea-AI Filing Summary

Solventum Corp director John H. Weiland exercised 3,403 Restricted Stock Units into 3,403 shares of Common Stock on April 30, 2026. The RSUs were fully vested and carried a conversion price of $0.00 per unit, giving him common shares without a cash outlay.

After this settlement, Weiland directly holds 8,947 shares of Common Stock and no remaining RSUs from this grant. This filing reflects a compensation-related derivative exercise rather than an open-market purchase or sale.

Insider Trade Summary

3,403 shares exercised/converted

Exercise 2 txns

Insider WEILAND JOHN H

Role Director

Type	Security	Shares	Price	Value
Exercise	Restricted Stock Units	3,403	$0.00	$0.00
Exercise	Common Stock	3,403	$0.00	$0.00

Holdings After Transaction: Restricted Stock Units — 0 contracts (Direct); Common Stock — 8,947 shares (Direct)

Footnotes (2)

1. F1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.
2. F2. The RSUs are fully vested.

Key Figures

RSUs exercised: 3,403 units Shares received: 3,403 shares Conversion price: $0.00 per unit +2 more

5 metrics

RSUs exercised 3,403 units Converted into Common Stock on April 30, 2026

Shares received 3,403 shares Common Stock issued upon RSU settlement

Conversion price $0.00 per unit RSU exercise/conversion price

Post-transaction holdings 8,947 shares Common Stock directly held after April 30, 2026

RSU expiration date April 30, 2035 Original RSU expiration before full exercise

Key Terms

Restricted Stock Units, contingent right, derivative exercise/conversion, Common Stock

4 terms

Restricted Stock Units financial

"security_title: "Restricted Stock Units" and footnote defining each RSU"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

contingent right financial

"Each Restricted Stock unit represents a contingent right to receive 1 share"

derivative exercise/conversion financial

"transaction_action: "derivative exercise/conversion" for the RSU transaction"

Common Stock financial

"underlying_security_title: "Common Stock" and non-derivative security_title"

Common stock represents ownership shares in a company, giving investors a stake in its success and a say in important decisions through voting rights. It is the most common type of stock traded on markets and can provide income through dividends, as well as potential for value growth. For investors, holding common stock means sharing in the company’s profits and risks.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transaction did Solventum (SOLV) report for John H. Weiland?

Solventum reported that director John H. Weiland exercised 3,403 Restricted Stock Units into 3,403 shares of Common Stock. This was a derivative exercise at a $0.00 conversion price, reflecting the settlement of equity compensation rather than an open-market trade.

How many Solventum (SOLV) shares does John H. Weiland hold after this Form 4?

After the transaction, John H. Weiland directly holds 8,947 shares of Solventum Common Stock. These shares result from the settlement of 3,403 fully vested Restricted Stock Units into an equal number of common shares on April 30, 2026.

Was the Solventum (SOLV) Form 4 transaction a stock sale or purchase?

The Form 4 shows a derivative exercise, not an open-market sale or purchase. Weiland settled 3,403 Restricted Stock Units into 3,403 Common Stock shares at a $0.00 conversion price, so there was no reported buy or sell on the market.

What are Restricted Stock Units (RSUs) in the Solventum (SOLV) filing?

In this filing, each Restricted Stock Unit represents a contingent right to receive one share of Solventum Common Stock upon settlement. The reported RSUs were fully vested and converted one-for-one into 3,403 shares on April 30, 2026.

Did John H. Weiland retain any derivative securities after this Solventum transaction?

The data show that no RSUs from this specific grant remained outstanding after settlement. The derivative position listed had 3,403 units, which were fully exercised into 3,403 Common Stock shares, leaving a reported derivative balance of zero.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/01/2026 - 04:30 PM EDT Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

WEILAND JOHN H

(Last) (First) (Middle)

1750 YANKEE DOODLE ROAD

(Street)

EAGAN MINNESOTA 55121

(City) (State) (Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
Solventum Corp [ SOLV ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
04/30/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	04/30/2026		M		3,403	A	$0	8,947	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares
Restricted Stock Units	(1)	04/30/2026		M			3,403	(2)	04/30/2035	Common Stock	3,403	$0	0	D

Explanation of Responses:

1. Each Restricted Stock unit ("RSU") represents a contingent right to receive 1 share of the issuer's Common Stock upon settlement.

2. The RSUs are fully vested.

Remarks:

	/s/Megan Bombick, attorney-in-fact for John H. Weiland	05/01/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)